BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16086426)

  • 41. Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy.
    Cheng FW; Lee V; To KF; Chan KC; Shing MK; Li CK
    Pediatr Blood Cancer; 2009 Dec; 53(7):1329-31. PubMed ID: 19591223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.
    Ahya VN; Douglas LP; Andreadis C; Arnoldi S; Svoboda J; Kotloff RM; Hadjiliadis D; Sager JS; Woo YJ; Pochettino A; Schuster SJ; Stadtmauer EA; Tsai DE
    J Heart Lung Transplant; 2007 Aug; 26(8):839-44. PubMed ID: 17692789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab.
    Garceau P; Couture C; Cantin B; Bernier V; Sénéchal M
    J Heart Lung Transplant; 2008 Aug; 27(8):928-31. PubMed ID: 18656811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
    Bakker NA; Verschuuren EA; Erasmus ME; Hepkema BG; Veeger NJ; Kallenberg CG; van der Bij W
    Transplantation; 2007 Feb; 83(4):433-8. PubMed ID: 17318076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment for Epstein-Barr virus-associated PTLD.
    Gross TG
    Herpes; 2009 Jan; 15(3):64-7. PubMed ID: 19306606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epstein-Barr virus-associated high-grade anaplastic plasmacytoma in a renal transplant patient.
    Papadaki HA; Stefanaki K; Kanavaros P; Katonis P; Papastathi H; Valatas W; Stylianoy K; Eliopoulos GD
    Leuk Lymphoma; 2000 Jan; 36(3-4):411-5. PubMed ID: 10674914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort.
    Katz BZ; Pahl E; Crawford SE; Kostyk MC; Rodgers S; Seshadri R; Proytcheva M; Pophal S
    Pediatr Transplant; 2007 Feb; 11(1):58-65. PubMed ID: 17239124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
    Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation].
    Liu QF; Fan ZP; Luo XD; Zhang Y; Sun J
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3123-6. PubMed ID: 19159594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development.
    Weinstock DM; Ambrossi GG; Brennan C; Kiehn TE; Jakubowski A
    Bone Marrow Transplant; 2006 Mar; 37(6):539-46. PubMed ID: 16462755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of reactive antibodies against epstein-barr in a group of renal transplant patients.
    Geramizadeh B; Aghdai M; Azarpira N; Behabahani AB; Heidari T; Banihashemi M; Raisjalali AR; Roozbeh J; Behzadi A
    Transplant Proc; 2005 Sep; 37(7):3051-2. PubMed ID: 16213301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
    D'Antiga L; Del Rizzo M; Mengoli C; Cillo U; Guariso G; Zancan L
    Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
    J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.
    Lim WH; Russ GR; Coates PT
    Nephrology (Carlton); 2006 Aug; 11(4):355-66. PubMed ID: 16889577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Post-transplant Lymphoproliferative Disorder--a case of late-onset T-cell lymphoma after failed renal transplant.
    Dalal P; Bichu P; Dhawan V; Ariyamuthu V; Malhotra K; Misra M; Khanna R
    Adv Perit Dial; 2012; 28():94-6. PubMed ID: 23311222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A quantitative assay for Epstein-Barr Virus-specific immunity shows interferon-gamma producing CD8+ T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease.
    Guppy AE; Rawlings E; Madrigal JA; Amlot PL; Barber LD
    Transplantation; 2007 Dec; 84(11):1534-9. PubMed ID: 18091531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Lymphoma in patients who have undergone organ transplantation: severe and variable clinical presentation].
    Bakker NA; van Imhoff GW; van Son WJ; Kluin PM; Kluin-Nelemans JC; Verschuuren EA
    Ned Tijdschr Geneeskd; 2008 May; 152(19):1077-80. PubMed ID: 18552058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A multilocular B-cell neoplasia presenting as multiple myeloma and polymorphic lymphoma of recipient origin 2 months after kidney transplantation in a heart-transplant recipient.
    Haas M; Mannhalter C; Ullrich R; Schwarzinger I; Zuckermann A; Derfler K; Jäger U
    Nephrol Dial Transplant; 1996 Oct; 11(10):2085-7. PubMed ID: 8918731
    [No Abstract]   [Full Text] [Related]  

  • 60. Epstein-Barr virus-associated enteritis with multiple ulcers after stem cell transplantation: first histologically confirmed case.
    Tashiro Y; Goto M; Takemoto Y; Sato E; Shirahama H; Utsunomiya A; Eizuru Y; Yonezawa S
    Pathol Int; 2006 Sep; 56(9):530-7. PubMed ID: 16930333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.